Header Logo

Connection

SRDAN VERSTOVSEK to Tubulin

Back to Details
This is a "connection" page, showing publications SRDAN VERSTOVSEK has written about Tubulin.
SRDAN VERSTOVSEK
Connection Strength
0.016
Tubulin
  1. Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies. Clin Cancer Res. 2005 Sep 15; 11(18):6615-24.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.